Rhinovirus-induced first wheezing episode predicts atopic but not nonatopic asthma at school age

Minna Lukkarinen, Annamari Koistinen, Riitta Turunen, Pasi Lehtinen, Tytti Vuorinen, Tuomas Jartti, Minna Lukkarinen, Annamari Koistinen, Riitta Turunen, Pasi Lehtinen, Tytti Vuorinen, Tuomas Jartti

Abstract

Background: Persistent childhood asthma is mainly atopy driven. However, limited data exist on the risk factors for childhood asthma phenotypes.

Objective: We sought to identify risk factors at the first severe wheezing episode for current asthma 7 years later and separately for atopic and nonatopic asthma.

Methods: One hundred twenty-seven steroid-naive children with the first severe wheezing episode (90% hospitalized/10% emergency department treated) were followed for 7 years. The primary outcome was current asthma at age 8 years, which was also analyzed separately as atopic and nonatopic asthma. Risk factors, including sensitization, viral cause, and other main asthma risk factors, were analyzed.

Results: At study entry, median age was 11 months (interquartile range, 6-16 months); 17% were sensitized, and 98% were virus positive. Current asthma (n = 37) at 8 years was divided into atopic (n = 19) and nonatopic (n = 18) asthma. The risk factors for current atopic asthma at study entry were sensitization (adjusted odds ratio [OR], 12; P < .001), eczema (adjusted OR, 4.8; P = .014), and wheezing with rhinovirus (adjusted OR, 5.0; P = .035). The risk factors for nonatopic asthma were the first severe respiratory syncytial virus/rhinovirus-negative wheezing episode (adjusted OR, 8.0; P = .001), first wheezing episode at age less than 12 months (adjusted OR, 7.3; P = .007), and parental smoking (adjusted OR, 3.8; P = .028).

Conclusions: The data suggest diverse asthma phenotypes and mechanisms that can be predicted by using simple clinical markers at the time of the first severe wheezing episode. These findings are important for designing early intervention strategies for secondary prevention of asthma.

Trial registration: ClinicalTrials.gov NCT00494624 NCT00731575.

Keywords: Allergy; atopy; bronchiolitis; child; eczema; respiratory syncytial virus; rhinovirus; sensitization; virus; wheeze; wheezing.

Copyright © 2017 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Figures

Fig 1
Fig 1
Study flow chart. ICU, Intensive care unit.
Fig 2
Fig 2
Incidence of current asthma phenotypes at age 8 years in children (n = 127) with sole and overlapping atopic risk factors (sensitization, eczema, rhinovirus, and parental asthma) at the first wheezing episode. N/A, Not applicable because there were no cases with risk factors.

References

    1. Lehtinen P., Ruohola A., Vanto T., Vuorinen T., Ruuskanen O., Jartti T. Prednisolone reduces recurrent wheezing after a first wheezing episode associated with rhinovirus infection or eczema. J Allergy Clin Immunol. 2007;119:570–575.
    1. Jackson D.J., Evans M.D., Gangnon R.E., Tisler C.J., Pappas T.E., Lee W.M. Evidence for a causal relationship between allergic sensitization and rhinovirus wheezing in early life. Am J Respir Crit Care Med. 2012;185:281–285.
    1. Kusel M.M., Kebadze T., Johnston S.L., Holt P.G., Sly P.D. Febrile respiratory illnesses in infancy and atopy are risk factors for persistent asthma and wheeze. Eur Respir J. 2012;39:876–882.
    1. Lukkarinen M., Lukkarinen H., Lehtinen P., Vuorinen T., Ruuskanen O., Jartti T. Prednisolone reduces recurrent wheezing after first rhinovirus wheeze: a 7-year follow-up. Pediatr Allergy Immunol. 2013;24:237–243.
    1. Jackson D.J., Gern J.E., Lemanske R.F., Jr. The contributions of allergic sensitization and respiratory pathogens to asthma inception. J Allergy Clin Immunol. 2016;137:659–665.
    1. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119:1105–1110.
    1. Jackson D.J., Gangnon R.E., Evans M.D., Roberg K.A., Anderson E.L., Pappas T.E. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178:667–672.
    1. Kurukulaaratchy R.J., Fenn M., Matthews S., Arshad S.H. Characterisation of atopic and non-atopic wheeze in 10 year old children. Thorax. 2004;59:563–568.
    1. Lukkarinen M., Vuorinen T., Lehtinen P., Ruuskanen O., Jartti T. Sensitization at the first wheezing episode increases risk for long-term asthma therapy. Pediatr Allergy Immunol. 2015;26:687–691.
    1. Castro-Rodriguez J.A., Holberg C.J., Wright A.L., Martinez F.D. A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403–1406.
    1. National Asthma Education and Prevention Program Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma—summary report 2007. J Allergy Clin Immunol. 2007;120(suppl):S94–S138.
    1. Rönmark E., Jönsson E., Platts-Mills T., Lundbäck B. Different pattern of risk factors for atopic and nonatopic asthma among children—report from the Obstructive Lung Disease in Northern Sweden Study. Allergy. 1999;54:926–935.
    1. Civelek E., Cakir B., Orhan F., Yuksel H., Boz A.B., Uner A. Risk factors for current wheezing and its phenotypes among elementary school children. Pediatr Pulmonol. 2011;46:166–174.
    1. Göksor E., Alm B., Pettersson R., Mollborg P., Erdes L., Aberg N. Early fish introduction and neonatal antibiotics affect the risk of asthma into school age. Pediatr Allergy Immunol. 2013;24:339–344.
    1. Edwards M.R., Regamey N., Vareille M., Kieninger E., Gupta A., Shoemark A. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol. 2013;6:797–806.
    1. Szefler S.J. Advances in pediatric asthma in 2013: coordinating asthma care. J Allergy Clin Immunol. 2014;133:654–661.
    1. Midulla F., Pierangeli A., Cangiano G., Bonci E., Salvadei S., Scagnolari C. Rhinovirus bronchiolitis and recurrent wheezing: one year follow-up. Eur Respir J. 2012;39:396–402.
    1. Jartti T., Nieminen R., Vuorinen T., Lehtinen P., Vahlberg T., Gern J. Short- and long-term efficacy of prednisolone for first acute rhinovirus-induced wheezing episode. J Allergy Clin Immunol. 2015;135:691–698.
    1. Turunen R., Koistinen A., Vuorinen T., Arku B., Söderlund-Venermo M., Ruuskanen O. The first wheezing episode: respiratory virus etiology, atopic characteristics, and illness severity. Pediatr Allergy Immunol. 2014;25:796–803.
    1. Lukkarinen M.M., Koistinen A.P., Turunen R.M., Jartti T.T. Toward primary prevention of asthma: role of corticosteroids for the first rhinovirus wheeze. Am J Respir Crit Care Med. 2015;192:1018–1019.
    1. Lukkarinen M., Jartti T. The first rhinovirus-wheeze acts as a marker for later asthma in high-risk children. J Allergy Clin Immunol. 2016;138:313.
    1. Jartti T., Lehtinen P., Vuorinen T., Ruuskanen O. Bronchiolitis: age and previous wheezing episodes are linked to viral etiology and atopic characteristics. Pediatr Infect Dis J. 2009;28:311–317.
    1. Jartti T., Kuusipalo H., Vuorinen T., Söderlund-Venermo M., Allander T., Waris M. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol. 2010;21:1008–1014.
    1. Jartti T., Lehtinen P., Vanto T., Hartiala J., Vuorinen T., Mäkelä M.J. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus. Pediatr Infect Dis J. 2006;25:482–488.
    1. Jartti T., Lehtinen P., Vuorinen T., Österback R., van den Hoogen B., Osterhaus A.D. Respiratory picornaviruses and respiratory syncytial virus as causative agents of acute expiratory wheezing in children. Emerg Infect Dis. 2004;10:1095–1101.
    1. Allander T., Jartti T., Gupta S., Niesters H.G., Lehtinen P., Osterback R. Human bocavirus and acute wheezing in children. Clin Infect Dis. 2007;44:904–910.
    1. Söderlund-Venermo M., Lahtinen A., Jartti T., Hedman L., Kemppainen K., Lehtinen P. Clinical assessment and improved diagnosis of bocavirus-induced wheezing in children. Finland. Emerg Infect Dis. 2009;15:1423–1430.
    1. Beydon N., Davis S.D., Lombardi E., Allen J.L., Arets H.G., Aurora P. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175:1304–1345.
    1. Bergroth E., Aakula M., Korppi M., Remes S., Kivisto J.E., Piedra P.A. Post-bronchiolitis use of asthma medication: a prospective 1-year follow-up study. Pediatr Infect Dis J. 2016;35:363–368.
    1. Stein R.T., Sherrill D., Morgan W.J., Holberg C.J., Halonen M., Taussig L.M. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354:541–545.
    1. Bousquet J., Gern J.E., Martinez F.D., Anto J.M., Johnson C.C., Holt P.G. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol. 2014;133:1535–1546.
    1. Bønnelykke K., Vissing N.H., Sevelsted A., Johnston S.L., Bisgaard H. Association between respiratory infections in early life and later asthma is independent of virus type. J Allergy Clin Immunol. 2015;136:81–86.
    1. Holt P.G., Sly P.D. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med. 2012;18:726–735.
    1. Holt P.G., Sly P.D. Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis. Chest. 2011;139:1165–1171.
    1. Durrani S.R., Montville D.J., Pratt A.S., Sahu S., Devries M.K., Rajamanickam V. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012;130:489–495.
    1. Nissen S.P., Kjaer H.F., Host A., Nielsen J., Halken S. The natural course of sensitization and allergic diseases from childhood to adulthood. Pediatr Allergy Immunol. 2013;24:549–555.
    1. Chiu C.Y., Huang Y.L., Tsai M.H., Tu Y.L., Hua M.C., Yao T.C. Sensitization to food and inhalant allergens in relation to atopic diseases in early childhood: a birth cohort study. PLoS One. 2014;9:e102809.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera